SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Fransson Moa)
 

Search: WFRF:(Fransson Moa) > The blood endotheli...

The blood endothelial cell chamber : an innovative system to study immune responses in drug development

Stancic, Brina (author)
Uppsala universitet,Institutionen för immunologi, genetik och patologi,Department of Molecular Biology, Universidad Autónoma de Madrid, and Department of Molecular Neuropathology, Center of Molecular Biology Severo Ochoa (UAM-CSIC), Nicolás Cabrera 1, 28049 Madrid, Spain,Dejana
Qvarfordt, Bodil (author)
Uppsala universitet,Institutionen för immunologi, genetik och patologi,Dejana
Berglund, Magnus M. (author)
BeMa BioConsulting AB, Törnvägen 23, 136 72 Vendelsö, Sweden
show more...
Brenden, Nina (author)
Swedish Orphan Biovitrum AB, Tomtebodavägen 23A, 112 76 Solna, Sweden
Sydow Bäckman, Mona (author)
Swedish Orphan Biovitrum AB, Tomtebodavägen 23A, 112 76 Solna, Sweden
Fransson, Moa, 1981- (author)
Uppsala universitet,Klinisk immunologi
Nordling, Sofia, 1985- (author)
Uppsala universitet,Vaskulärbiologi
Magnusson, Peetra (author)
Uppsala universitet,Vaskulärbiologi,Dejana
show less...
 (creator_code:org_t)
Elsevier BV, 2021
2021
English.
In: International Journal of Immunopharmacology. - : Elsevier BV. - 0192-0561 .- 1879-3495. ; 90
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • The risk for adverse immune-mediated reactions, associated with the administration of certain immunotherapeutic agents, should be mitigated early. Infusion reactions to monoclonal antibodies and other biopharmaceuticals, known as cytokine release syndrome, can arise from the release of cytokines via the drug target cell, as well as the recruitment of immune effector cells. While several in vitro cytokine release assays have been proposed up to date, many of them lack important blood components, required for this response to occur. The blood endothelial cell chamber model is an in vitro assay, composed of freshly drawn human whole blood and cultured human primary endothelial cells. Herein, its potential to study the compatibility of immunotherapeutics with the human immune system was studied by evaluating three commercially available monoclonal antibodies and bacterial endotoxin lipopolysaccharide. We demonstrate that the anti-CD28 antibody TGN1412 displayed an adaptive cytokine release profile and a distinct IL-2 response, accompanied with increased CD3+ cell recruitment. Alemtuzumab exhibited a clear cytokine response with a mixed adaptive/innate source (IFNγ, TNFα and IL-6). Its immunosuppressive nature is observed in depleted CD3+ cells. Cetuximab, associated with low infusion reactions, showed a very low or absent stimulatory effect on proinflammatory cytokines. In contrast, bacterial endotoxin demonstrated a clear innate cytokine response, defined by TNFα, IL-6 and IL-1β release, accompanied with a strong recruitment of CD14+CD16+ cells. Therefore, the blood endothelial cell chamber model is presented as a valuable in vitro tool to investigate therapeutic monoclonal antibodies with respect to cytokine release and vascular immune cell recruitment. 

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Immunologi inom det medicinska området (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Immunology in the medical area (hsv//eng)

Keyword

Immunologi
Immunology

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view